Columnist Betty Vertin recognizes the admirable traits in those living with Duchenne muscular dystrophy — and their moms.

Treatment with preventive heart medications can extend survival among males with Duchenne muscular dystrophy (DMD), a new ...

The FDA has lifted its hold and has given Entrada Therapeutics permission to launch a Phase 1b clinical trial to test ...

Five oculopharyngeal muscular dystrophy (OPMD) patients have now been treated with the gene therapy candidate BB-301 in a ...

People with Duchenne or Becker muscular dystrophy who had more siblings typically report being better prepared to transition ...

Five people with oculopharyngeal muscular dystrophy (OPMD) — a type of muscular dystrophy marked by muscle weakness affecting the face and throat — have thus far been treated with the gene therapy ...

Working with his girlfriend, columnist Shalom Lim has formed an arts collective dedicated to promoting inclusion and creative expression.

FSHD has made an increasing number of everyday items unusable for columnist Robin Stemple because they're too heavy.

Reflecting on his sudden hospitalization last year, columnist Patrick Moeschen emphasizes the need to create an emergency medical plan.

Enrollment of healthy volunteers for a Phase 1 trial testing Duchenne muscular dystrophy (DMD) treatment candidate SAT-3247 is now complete.